Withdrawing biologics in non-systemic JIA: what matters to pediatric rheumatologists?

Janine A van TilMichelle M A KipEllen J H SchatorjéGillian CurrieMarinka TwiltSusanne M BenselerJoost F SwartSebastiaan J VastertNico WulffraatRae S M YeungC G M Karin Groothuis-OudshoornSanne WartaDeborah A MarshallMaarten J IJzermannull null

Published in: Pediatric rheumatology online journal (2023)

Patient's and parents' preferences were the strongest driver of a decision to postpone biologic therapy withdrawal in children with clinically inactive non-systemic JIA and prolongs treatment duration. These findings highlight the potential benefit of a tool to support pediatric rheumatologists, patients and parents in decision making, and can help inform its design.

Keyphrases

decision making
end stage renal disease
ejection fraction
newly diagnosed
rheumatoid arthritis
peritoneal dialysis
case report
stem cells
patient reported outcomes
systemic lupus erythematosus
bone marrow
mesenchymal stem cells
human health